Guardian Investment Management Has Boosted Its Boeing Co (BA) Holding; Amgen (AMGN) Shareholder Old Point Trust & Financial Services N A Has Raised Stake

Amgen Inc. (NASDAQ:AMGN) Logo

Guardian Investment Management increased its stake in Boeing Co (BA) by 67.96% based on its latest 2018Q2 regulatory filing with the SEC. Guardian Investment Management bought 4,750 shares as the company’s stock declined 2.87% while stock markets rallied. The institutional investor held 11,739 shares of the aerospace company at the end of 2018Q2, valued at $3.94 million, up from 6,989 at the end of the previous reported quarter. Guardian Investment Management who had been investing in Boeing Co for a number of months, seems to be bullish on the $188.48B market cap company. The stock decreased 3.09% or $10.6 during the last trading session, reaching $331.9. About 9.30 million shares traded or 127.06% up from the average. The Boeing Company (NYSE:BA) has risen 46.90% since December 7, 2017 and is uptrending. It has outperformed by 31.28% the S&P500. Some Historical BA News: 14/03/2018 – GE AVIATION BEGINS FLIGHT TESTING OF GE9X ENGINE FOR BOEING 777X AFTER DELAY – DOCUMENT; 22/03/2018 – Trump’s big tariff blow on China may cause a backlash against Boeing; 09/05/2018 – BOEING’S MUILENBURG SPEAKS AT THE ECONOMIC CLUB OF WASHINGTON; 21/03/2018 – CHINA SOUTHERN UNIT TO BUY 20 B737-8, 10 B737-10 FROM BOEING; 25/05/2018 – BOEING’S LEVERKUHN IS WORKING AT ROLLS FACTORIES, PEOPLE SAY; 13/04/2018 – Boeing Says Deploying Support Teams to Mitigate Impact of Extra Rolls-Royce Inspections; 17/04/2018 – EXCLUSIVE-NEW INITIATIVE WILL PROVIDE GUIDELINES TO SPEED UP APPROVAL OF U.S. ARMS EXPORTS TO CERTAIN ALLIES; 05/03/2018 – BOEING EXEC SEES 5 PCT OF 2018 DELIVERIES FINANCED BY INSURANCE INDUSTRY THIS YEAR, UP FROM 2 PCT IN 2017; 26/04/2018 – BOEING – THROUGH UNIT, AVIALL SIGNED PARTS DISTRIBUTION DEAL WITH GE AVIATION; 06/03/2018 – BOEING – HAWAIIAN INTENDS TO PURCHASE 10 787-9 JETS VALUED AT $2.82 BLN AT LIST PRICES

Old Point Trust & Financial Services N A increased its stake in Amgen Inc (AMGN) by 8.54% based on its latest 2018Q2 regulatory filing with the SEC. Old Point Trust & Financial Services N A bought 2,195 shares as the company’s stock rose 8.61% with the market. The institutional investor held 27,907 shares of the biological products (no diagnostic substances) company at the end of 2018Q2, valued at $5.15 million, up from 25,712 at the end of the previous reported quarter. Old Point Trust & Financial Services N A who had been investing in Amgen Inc for a number of months, seems to be bullish on the $126.81B market cap company. The stock increased 0.63% or $1.25 during the last trading session, reaching $199.01. About 3.43M shares traded or 17.34% up from the average. Amgen Inc. (NASDAQ:AMGN) has risen 4.45% since December 7, 2017 and is uptrending. It has underperformed by 11.17% the S&P500. Some Historical AMGN News: 24/04/2018 – Amgen 1Q Adj EPS $3.47; 09/03/2018 – New Analyses Show Payer Utilization Management Criteria Deny Access To PCSK9 Inhibitors For Patients At The Highest Risk For Subsequent Cardiovascular Events; 17/05/2018 – AMGEN AMGN.O SETS LIST PRICE FOR AIMOVIG MIGRAINE DRUG AT $6,900 PER YEAR, OR $575 PER MONTH; 05/04/2018 – AbbVie Announces Global Resolution of HUMIRA┬« (adalimumab) Patent Disputes with Samsung Bioepis; 16/03/2018 – Biotechnology Companies with Great Potential; 29/03/2018 – FDA: FDA granted accelerated approval to blinatumomab (Blincyto, Amgen Inc.) for the treatment of adult and pediatric patients; 21/05/2018 – FDA Approves Prolia┬« (Denosumab) For Glucocorticoid-lnduced Osteoporosis; 17/05/2018 – Novartis and Amgen announce FDA approval of Aimovig(TM) (erenumab), a novel treatment developed specifically for migraine prevention; 25/04/2018 – Sales of cholesterol medication Repatha more than doubled to $123 million, beating expectations; 17/04/2018 – Amgen Presents First-Of-Its-Kind Data At AAN Annual Meeting Reinforcing Robust And Consistent Efficacy Of Aimovig™ (erenumab) For Migraine Patients With Multiple Treatment Failures

Investors sentiment increased to 0.99 in Q2 2018. Its up 0.11, from 0.88 in 2018Q1. It increased, as 42 investors sold AMGN shares while 528 reduced holdings. 117 funds opened positions while 447 raised stakes. 483.36 million shares or 3.85% less from 502.72 million shares in 2018Q1 were reported. Aull & Monroe Inv Mgmt invested 1.45% in Amgen Inc. (NASDAQ:AMGN). Stelliam Invest Management Limited Partnership stated it has 1.39% in Amgen Inc. (NASDAQ:AMGN). South State Corp stated it has 57,396 shares or 1.19% of all its holdings. Palladium Partners Ltd Limited Liability Company holds 82,091 shares. Amalgamated Bank owns 0.46% invested in Amgen Inc. (NASDAQ:AMGN) for 102,406 shares. Fca Tx invested 1.35% in Amgen Inc. (NASDAQ:AMGN). Country Club Com Na reported 2.17% in Amgen Inc. (NASDAQ:AMGN). Fiera Capital invested 0.19% in Amgen Inc. (NASDAQ:AMGN). Texas-based Tctc Ltd Limited Liability Company has invested 0.35% in Amgen Inc. (NASDAQ:AMGN). Moreover, Abner Herrman Brock Ltd Liability has 1.52% invested in Amgen Inc. (NASDAQ:AMGN). E&G LP reported 0.23% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Arvest Bankshares Division, a Oklahoma-based fund reported 1,105 shares. 29,578 were reported by Moors & Cabot. 1.28 million are owned by Credit Suisse Ag. Azimuth Cap Mngmt Ltd Llc owns 7,858 shares.

Among 27 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 16 Hold. Therefore 41% are positive. Amgen Inc. had 99 analyst reports since August 3, 2015 according to SRatingsIntel. The stock of Amgen Inc. (NASDAQ:AMGN) has “Buy” rating given on Friday, July 21 by BMO Capital Markets. Citigroup initiated Amgen Inc. (NASDAQ:AMGN) on Thursday, February 25 with “Neutral” rating. The firm has “Overweight” rating given on Wednesday, October 31 by Morgan Stanley. The stock has “Outperform” rating by Credit Suisse on Wednesday, January 20. The stock has “Hold” rating by BMO Capital Markets on Friday, October 20. The rating was maintained by UBS on Wednesday, July 26 with “Neutral”. The rating was maintained by RBC Capital Markets with “Hold” on Thursday, October 26. The rating was maintained by BMO Capital Markets on Friday, February 2 with “Market Perform”. Mizuho initiated Amgen Inc. (NASDAQ:AMGN) on Tuesday, November 8 with “Buy” rating. The firm has “Overweight” rating by Piper Jaffray given on Thursday, November 5.

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: Prnewswire.com which released: “Amgen To Present At The Citi Global Healthcare Conference – PRNewswire” on November 30, 2018, also Nasdaq.com with their article: “Health Care Sector Update for 11/07/2018: INGN, AXDX, FOMX, JNJ, PFE, ABT, MRK, AMGN – Nasdaq” published on November 07, 2018, Seekingalpha.com published: “Key events next week – healthcare – Seeking Alpha” on November 30, 2018. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Nasdaq.com and their article: “Health Care Sector Update for 11/14/2018: CGC, CDNA, TLRY, JNJ, PFE, ABT, MRK, AMGN – Nasdaq” published on November 14, 2018 as well as Streetinsider.com‘s news article titled: “Amgen (AMGN), UCB Announce FDA Advisory Committee Meeting To Review EVENITY – StreetInsider.com” with publication date: November 30, 2018.

Since June 12, 2018, it had 0 insider buys, and 1 insider sale for $281,012 activity.

Among 27 analysts covering Boeing (NYSE:BA), 20 have Buy rating, 1 Sell and 6 Hold. Therefore 74% are positive. Boeing had 126 analyst reports since August 26, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Hold” on Friday, October 6. The stock of The Boeing Company (NYSE:BA) has “Buy” rating given on Thursday, April 28 by Argus Research. The rating was downgraded by JP Morgan to “Neutral” on Friday, February 12. The firm earned “Buy” rating on Thursday, February 1 by Credit Suisse. The firm has “Buy” rating by Jefferies given on Friday, September 22. The stock of The Boeing Company (NYSE:BA) has “Sector Perform” rating given on Thursday, September 3 by RBC Capital Markets. The company was maintained on Wednesday, January 31 by RBC Capital Markets. The rating was downgraded by Buckingham Research on Monday, February 13 to “Underperform”. RBC Capital Markets initiated The Boeing Company (NYSE:BA) rating on Thursday, January 12. RBC Capital Markets has “Underperform” rating and $136 target. The stock has “Hold” rating by Goldman Sachs on Thursday, July 27.

More notable recent The Boeing Company (NYSE:BA) news were published by: 247Wallst.com which released: “Lockheed Martin, Airbus Team Up to Supply a Tanker in Case the Air Force Needs One That Works – 24/7 Wall St.” on December 05, 2018, also Seekingalpha.com with their article: “Boeing cancels satellite project financed by China – Seeking Alpha” published on December 07, 2018, Seekingalpha.com published: “Boeing’s KC-46 tankers complete phase two receiver certification testing – Seeking Alpha” on December 03, 2018. More interesting news about The Boeing Company (NYSE:BA) were released by: Seekingalpha.com and their article: “Airbus prepares to fend off Boeing 797 – Seeking Alpha” published on November 26, 2018 as well as Seekingalpha.com‘s news article titled: “Airbus, Lockheed join forces for refueling orders – Seeking Alpha” with publication date: December 04, 2018.

Since October 29, 2018, it had 0 insider buys, and 2 selling transactions for $2.35 million activity. The insider Sands Diana L sold $1.75 million.

Investors sentiment increased to 0.88 in 2018 Q2. Its up 0.22, from 0.66 in 2018Q1. It is positive, as 38 investors sold BA shares while 606 reduced holdings. 121 funds opened positions while 445 raised stakes. 353.55 million shares or 2.04% less from 360.90 million shares in 2018Q1 were reported. Swiss Bank & Trust holds 0.71% of its portfolio in The Boeing Company (NYSE:BA) for 1.85M shares. Texas Yale Corp reported 25,726 shares. Iat Reinsurance Ltd reported 1.36% stake. Captrust Financial Advsrs accumulated 0.41% or 21,894 shares. Lucas Cap Mgmt holds 0.25% or 794 shares. Noesis Mangement holds 2,263 shares or 0.28% of its portfolio. Crossvault Cap Management Limited Liability has 5.57% invested in The Boeing Company (NYSE:BA). Sit Investment Assoc holds 0.44% of its portfolio in The Boeing Company (NYSE:BA) for 50,824 shares. Smith Chas P & Assocs Pa Cpas reported 60,444 shares. First Midwest Financial Bank Division reported 0.71% stake. 87,407 were reported by Bowen Hanes And Comm. Boyd Watterson Asset Limited Liability Co Oh holds 2.73% or 14,163 shares in its portfolio. Usa Financial Portformulas Corporation owns 20,018 shares for 1.59% of their portfolio. Freestone Cap Holding Ltd Liability Corp has invested 0.01% of its portfolio in The Boeing Company (NYSE:BA). Renaissance Technologies Lc reported 349,900 shares.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.